http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016203587-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate | 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c784125efa09eee182fc8ddbad8af5ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2826280f6142c0d3695722966737956b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633628f1a58363670a85ccece90ef010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09cbc6f26333443bfd9739ff010aeec1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d50d18ce489eab1847e10e49f282da9a |
| publicationDate | 2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2016203587-A1 |
| titleOfInvention | Antagonists of PCSK9 |
| abstract | ANTAGONISTS OF PCSK9 Antagonists of human proprotein convertase subtilisin-kexin type 9 ("PCSK9") are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. |
| priorityDate | 2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.